Please login to the form below

Not currently logged in

Takeda’s HAE drug Takhzyro backed by NICE

New treatment option for rare, hereditary disease

Roche wins FDA breakthrough for Gazyva in lupus nephritis

Roche - Basel, SwitzerlandDrug originally approved as a lymphoma treatment

FDA starts speedy review of Merck’s Ebola vaccine

First company to file for approval in the US

J&J's Tremfya filed for approval in US for psoriatic arthritis

Seeking share of increasingly competitive psoriasis market

Aimmune gets FDA panel backing for peanut allergy therapy

AimmuneStep closer to becoming first approved treatment

FDA fast-tracks AstraZeneca’s Farxiga in heart failure

AstraZeneca AZRaces to become first-in-class

AbbVie/Allergan's merger faces public opposition

AbbVie RedwoodAdvocacy groups and unions in the US express concerns

NICE approves BioMarin’s Brineura after initial setback

BiomarinFirst treatment for rare disease

Brexit‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Latest regulatory appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...